Imaging Technology News - November/December 2008 - (Page 43)

> > special report Imaging Market continued on page 43 Medical Imaging Market by Segment, U.S., 2008. Contrast agents and contrast injectors In 2008, the contrast agent market was valued at over $1.7 billion and the contrast agent injector market was valued at over $70 million. All segments in this market are expected to exhibit a steady growth in value throughout the forecast period, despite a continuous decline in prices. The ultrasound contrast agent market is growing the fastest and is estimated to more than double by 2015. The MRI contrast agent market grew 5.5 percent this year over 2007, and is forecasted to grow at an even faster rate by 2015. The X-ray/CT contrast agent market is growing the slowest of the agents, as it is the most mature market and has far more products available than the other two. The contrast injector market, which is mainly driven by replacements, is expected to reach almost $100 million by 2015. Competitive analysis In 2008, GE Healthcare was the dominant player in the medical imaging equipment market in the U.S. They are the only company that participates in every segment, and have managed to successfully penetrate every market and retain their customers. With the exception of nuclear medicine, they hold the most share in every segment. Their strong focus on innovation and dedication to providing reliable service has enabled them to stay ahead in the imaging market. Siemens Medical Solutions was the second leading competitor in the market in 2008. They have products in every market except for the contrast agents and injector market. They are the leading competitor in the nuclear medicine market, which is a relatively small but significant imaging segment. While they have a wide variety of systems, Siemens has been successful in offering top of the line products. Leading Competitors, Medical Imaging Market, U.S., 2008 Source: iData Research Inc. expected to reach over $291 million by 2015. Some of the smaller specialty markets are also in their growth phases and are forecasted to become significant market segments by 2015. Computed tomography imaging In 2008, the overall computed tomography (CT) system market was valued at almost $1.4 billion in the U.S., representing a 2.4 percent increase over 2007. The market for CT systems includes the 16-slice, 32/40-slice, 64-slice and ultra-premium (over 64slice) markets. This market was also one of the most heavily affected by the implementation of the DRA. Despite the temporary decline it has caused, all markets are expected to exhibit a modest positive growth by 2015. There is a clear trend in this market toward higher slice systems as they produce more accurate images, as can be understood by the higher growth of the 64-slice segment. Due to this trend, the premium market (systems with a slice count of over 64) was initially expected to experience the same level of growth, however, that did not occur due to the current state of the economy and the very high average selling prices of these systems. Nuclear medicine imaging This market includes PET/CT, SPECT and SPECT/CT systems. The growth of the overall market is a result of the trend toward hybrid systems, which allow physicians to better pinpoint abnormalities in the body by combining the functional information provided by the PET or SPECT aspect with the anatomical information given in a CT scan. As a result, the PET/CT has completely eclipsed the PET market. The SPECT/CT market, exhibiting a CAGR of 9.4 percent, is expected to cannibalize the SPECT market, which is estimated to experience a continuous decline through the end of the forecast period. While the nuclear medicine imaging market suffered a sharp decline in 2007, and is still struggling, the hybrid markets are expected to recover and resume positive growth by 2010. Medical Imaging Equipment Market, U.S., 2005-2015 15000 Source: iData Research Inc. Philips Medical Systems was very close behind Siemens in the imaging market in 2008. They also offer products in every segment except for the contrast agent and injector market. Philips has done particularly well in the X-ray and ultrasound markets, where their award-winning high performance cardiovascular imaging systems have been very well-received. special report > 43 http://new.reillycomm.com/imaging/special-report-b.php

Table of Contents Feed for the Digital Edition of Image Technology News - November 2008

Image Technology News - November 2008 Contents RSNA CT Systems Imaging An Image is Worth a Thousand Words Ultrasound Systems MBI Takes on FFDM Trouble in Multi-PACS Paradise When is Appropriateness Criteria Appropriate? RIS/PACS in a Web 2.0 World Digital Mammography Helps Center Continue its Commitment to the Best in Patient-Focused Breast Cancer Cardiovascular Imaging Systems PARCA Extends Expertise to World PACS Market

Image Technology News - November 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.